AI assistant
AMICUS THERAPEUTICS, INC. — Director's Dealing 2017
Jan 5, 2017
31523_dirs_2017-01-05_df593dac-2c3a-4f65-96fa-c35ce568f58c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2017-01-03
Reporting Person: Campbell Bradley L (Chief Operating Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-01-03 | Common Stock | A | 74525 | $0.00 | Acquired | 127475 | Direct |
| 2017-01-03 | Common Stock | M | 100000 | — | Acquired | 227475 | Direct |
| 2017-01-03 | Common Stock | F | 50950 | $5.13 | Disposed | 176525 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-01-03 | Stock Options (right to buy) | $5.13 | A | 103578 | Acquired | 2027-01-03 | Common Stock (103578) | Direct |
| 2017-01-03 | Restricted Stock Units | $ | M | 100000 | Disposed | Common Stock (100000) | Direct |
Footnotes
F1: Restricted stock units convert into common stock on a one-for-one basis.
F2: These options vest and become exercisable in a series of installments. The first installment, which consists of 25% of the total aggregate number of options granted, vests on January 3, 2018. The remaining options vest and become exercisable in a series of thirty-five successive equal monthly installments, beginning on February 1, 2018, with the final installment vesting on January 1, 2021.
F3: On June 26, 2014, the reporting person was granted 100,000 restricted stock units, vesting in full on July 1, 2016.